Home

Robert Rosen

CIK 1555089 · President · last filed 2022-08-24

Robert Rosen is a President who has filed 26 SEC Form 4 insider transactions across 3 companies since 2014. Across all open-market trades the lifetime net is −$15.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $42.2K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$42.2K

Companies

3

Total Filings

26

Lifetime Open-Market Net

-$15.75M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Director — $6.22 — $0 9 2022-01-14
Odonate Therapeutics, Inc. (ODT) Delisted Director — $1.12 — $0 4 2020-12-10
HRTX President 98,171 $0.43 $42.2K -$15.75M 8 2018-12-18

Recent Filings

26 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2022-08-24 — Disp (D) — $0
2022-01-14 LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Grant (A) — $0 EDGAR
2020-12-14 LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Grant (A) — $0 EDGAR
2020-12-10 Odonate Therapeutics, Inc. (ODT) Delisted Grant (A) — $0 EDGAR
2019-12-23 LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Grant (A) — $0 EDGAR
2019-12-12 Odonate Therapeutics, Inc. (ODT) Delisted Grant (A) — $0 EDGAR
2019-01-25 LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Grant (A) — $0 EDGAR
2019-01-03 Odonate Therapeutics, Inc. (ODT) Delisted Grant (A) — $0 EDGAR
2018-12-18 HRTX Grant (A) — $0 EDGAR
2018-07-03 HRTX Mixed — -$7.15M EDGAR
Showing 1–10 of 26
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.